Showing results (121-130 of 189) with videos related to

Sort By:
Pageof 19
Seminars in Cutaneous Medicine and Surgery|July 18, 2018
Highlights of Skin Disease Education Foundations 42nd Annual Hawaii Dermatology SeminarHilary E Baldwin, Linda F Stein Gold, Kenneth B Gordon, et al.
Journal of the American Academy of Dermatology|September 23, 2014
A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasisKenneth B Gordon, Craig L Leonardi, Mark Lebwohl, et al.
Tumori|June 11, 1999
Relationship between the shape and size of radiofrequency induced thermal lesions and hepatic vascularizationS Rossi, F Garbagnati, I De Francesco, et al.
The British Journal of Dermatology|October 13, 2006
Efalizumab-induced autoimmune pancytopeniaW L Tom, M D Miller, M Y Hurley, et al.
The Cancer Journal From Scientific American|November 1, 1996
Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patientsC Aristei, F Aversa, C Raymondi, et al.
Archives of Dermatology|December 1, 1993
Identification of Mycobacterium tuberculosis DNA in five different types of cutaneous lesions by the polymerase chain reactionN S Penneys, C L Leonardi, S Cook, et al.
Journal of the American Academy of Dermatology|October 22, 2011
Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasisDavid M Pariser, Craig L Leonardi, Kenneth Gordon, et al.
La Clinica Terapeutica|June 17, 2025
Inflammatory signatures and immunomodulation in neonates: a pilot studyL Leonardi, V Pennetta, R Laitano, et al.
International Journal of Immunopathology and Pharmacology|July 10, 2014
Risk factors affecting quality of life in a group of Italian children with asthmaL Indinnimeo, F Chiarotti, V De Vittori, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 2, 2021
Treatment with SDZ-ADL, an Adalimumab Biosimilar, in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis: Results of Patient-Reported Outcome Measures from Two Phase III Studies (ADMYRA and ADACCESS)Andrew Blauvelt, Craig L Leonardi, Norman Gaylis, et al.
Pageof 19